Effect [qlco]
fluvastatin [orch, phsu]
Apolipoprotein [aapp, bacs]
Defined [cnce]
Lipoprotein [aapp, bacs]
subclasses [clas]
Patients [podg]
Chronic renal insufficiency [dsyn]
concept [idcn]
Apolipoprotein [aapp, bacs]
Defined [cnce]
Lipoproteins [aapp, bacs]
Apo A-I [aapp, bacs]
Containing [ftcn]
Lipoproteins [aapp, bacs]
CONSIST [qlco]
Two [qnco]
subclasses [clas]
referred [ftcn]
To [qlco]
lipoprotein A-I [aapp]
lipoprotein A-I [aapp]
Ii [aapp]
LPA [lbpr]
I- [inch]
Ii [aapp]
Apo-B [aapp, bacs]
Containing [ftcn]
Lipoproteins [aapp, bacs]
Five [qnco]
subclasses [clas]
Lipoprotein [aapp, bacs]
Lipoprotein [aapp, bacs]
[c] [qnco]
Lipoprotein [aapp, bacs]
Lipoprotein [aapp, bacs]
Lipoprotein [aapp, bacs]
Lipoprotein [aapp, bacs]
Lipoprotein [aapp, bacs]
lipoprotein A-II [aapp]
D NOS [aapp, imft]
LPA [lbpr]
Ii [aapp]
D NOS [aapp, imft]
Purpose [ftcn]
Study [mnob]
To [qlco]
Levels [qlco]
Apo A-I [aapp, bacs]
Apo-B [aapp, bacs]
Containing [ftcn]
Lipoprotein [aapp, bacs]
subclasses [clas]
fluvastatin [orch, phsu]
treatment [ftcn]
Patients [podg]
Chronic renal insufficiency [dsyn]
Apo A-I [aapp, bacs]
Apo-B [aapp, bacs]
Containing [ftcn]
Lipoprotein [aapp, bacs]
subclasses [clas]
Measured [qlco]
Patients [podg]
Renal Failure, Chronic [dsyn]
Asymptomatic [fndg]
Subject [grup]
Effect [qlco]
fluvastatin [orch, phsu]
Lipoprotein [aapp, bacs]
subclasses [clas]
randomized [resa]
Double-Blind Study [resa]
placebo-controlled [resa]
Two [qnco]
treatment [ftcn]
cross over [genf]
Patients [podg]
Administered [ftcn]
fluvastatin [orch, phsu]
placebo [topp]
weeks [tmco]
randomized [resa]
Order [inpr]
Patients [podg]
Characterized [acty]
High [qlco]
Levels [qlco]
Lipoprotein [aapp, bacs]
P NOS [aapp, imft]
Lipoprotein [aapp, bacs]
[c] [qnco]
P NOS [aapp, imft]
Lipoprotein [aapp, bacs]
P NOS [aapp, imft]
Slightly [idcn]
High [qlco]
Levels [qlco]
Lipoprotein [aapp, bacs]
LPA [lbpr]
Ii [aapp]
D NOS [aapp, imft]
Control [grup]
Levels [qlco]
LPA [lbpr]
I- [inch]
Ii [aapp]
Lower [spco]
P NOS [aapp, imft]
Patients [podg]
Control [grup]
fluvastatin [orch, phsu]
treatment [ftcn]
Reduced [qlco]
Apo-B [aapp, bacs]
Containing [ftcn]
subclasses [clas]
Only [qnco]
Reduced [qlco]
Level [qlco]
Lipoprotein [aapp, bacs]
Subclass [clas]
statistically significant [qnco]
P NOS [aapp, imft]
Levels [qlco]
LPA [lbpr]
I- [inch]
LPA [lbpr]
I- [inch]
Ii [aapp]
Not [ftcn]
Affected [ftcn]
fluvastatin [orch, phsu]
treatment [ftcn]
Reduced [qlco]
Normalized [resa]
Lipoprotein [aapp, bacs]
Lipoprotein [aapp, bacs]
subclasses [clas]
Slightly [idcn]
Reduced [qlco]
Levels [qlco]
Markedly [qlco]
Atherogenesis [patf]
Lipoprotein [aapp, bacs]
[c] [qnco]
Subclass [clas]
Not [ftcn]
Normalized [resa]
Potential [qlco]
Role [socb]
Lipoprotein [aapp, bacs]
progression [patf]
coronary artery disease [dsyn]
Chronic renal insufficiency [dsyn]
To [qlco]
Future [tmco]
studies [lbpr]
